CARD6 protects against collagen-induced rheumatoid arthritis in mice through attenuating the inflammatory response and joint destruction via suppression of TNFR1/TRAF2 signaling
Authors:
- 1 June 2020
- journal article
- research article
- Published by Elsevier in Biochemical and Biophysical Research Communications
- Vol. 526 (4) , 1092-1099
Abstract
No abstract availableKeywords
This publication has 32 references indexed in Scilit:
- High-density genetic mapping identifies new susceptibility loci for rheumatoid arthritisNature Genetics, 2012
- Hypoxia—a key regulator of angiogenesis and inflammation in rheumatoid arthritisNature Reviews Rheumatology, 2012
- Expression of CARD6, an NF-κB activator, in gastric, colorectal and oesophageal cancersPathology, 2010
- Bortezomib attenuates murine collagen-induced arthritisAnnals of the Rheumatic Diseases, 2009
- Current perspective of TACE inhibitors: A reviewBioorganic & Medicinal Chemistry, 2009
- The future of the IL-1 receptor antagonist anakinra: from rheumatoid arthritis to adult-onset Still's disease and systemic-onset juvenile idiopathic arthritisExpert Opinion on Investigational Drugs, 2008
- Collagen-induced arthritisNature Protocols, 2007
- Evidence that TNF-TNFR1-TRADD-TRAF2-RIP-TAK1-IKK pathway mediates constitutive NF-κB activation and proliferation in human head and neck squamous cell carcinomaOncogene, 2006
- CARD6 Is a Modulator of NF-κB Activation by Nod1- and Cardiak-mediated PathwaysJournal of Biological Chemistry, 2003
- Apoptosis as a therapeutic tool in rheumatoid arthritisNature Reviews Immunology, 2002